CEO: Joseph K. Belanoff

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Key numbers

Market Capitalization:1849676280
Shares Outstanding: 114602000
Float: 103291356
Next Earning Date:2020-08-04
TTm EPS: 0.9272
TTm Dividend Rate:
200 days moving average:13.74
50 days moving average: 15.94
One day percent Change: -7.03

2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,